Immunic IMUX
NASDAQ IMUX
$9.30 +0.39 (+4.38%)
At close: Sep 30, 2026 · 4:00 PM EDT

Immunic (IMUX) Capital Expenditures (2013 - 2026)

Updated

Immunic (IMUX) posted Capital Expenditures of $249,000 for Q2 2026, up 591.7% from $36,000 a year earlier.

Analysis

Immunic (IMUX) Capital Expenditures (2013 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Immunic was $329,000, up 141.9% year-over-year; for FY2025, it came in at $161,000, down 39.0% from FY2024.

  • Annual Capital Expenditures shows a five-year compound annual growth rate of 2.0% (FY2020 to FY2025).
  • In prior years, Immunic's Capital Expenditures was $264,000 in FY2024 (-21.0%), $334,000 in FY2023 (+198.2%), $112,000 in FY2022 (+67.2%) and $67,000 in FY2021 (-54.1%).
  • The Q2 2026 figure stands as the highest quarterly Capital Expenditures since Q1 2017.
  • On a year-over-year basis, Capital Expenditures increased in five of the last eight quarters, with growth averaging 85.5%.
  • The strongest year-over-year quarter for Capital Expenditures in the past five years was Q1 2023, with growth of 766.7%; the weakest was Q4 2024, with a decline of 98.2%.
  • According to Business Quant data, Capital Expenditures for the three prior quarters was $2,000 (Q1 2026), $11,000 (Q4 2025) and $67,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 Immunic 395.38 Mn 395.38 Mn - 249,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 249,000.00
Mar 31, 2026 2,000.00
Dec 31, 2025 11,000.00
Sep 30, 2025 67,000.00
Jun 30, 2025 36,000.00
Mar 31, 2025 47,000.00
Dec 31, 2024 3,000.00
Sep 30, 2024 50,000.00
Jun 30, 2024 180,000.00
Mar 31, 2024 31,000.00
Dec 31, 2023 165,000.00
Sep 30, 2023 44,000.00
Jun 30, 2023 21,000.00
Mar 31, 2023 104,000.00
Dec 31, 2022 -1,000.00
Sep 30, 2022 73,000.00
Jun 30, 2022 28,000.00
Mar 31, 2022 12,000.00
Dec 31, 2021 19,000.00
Sep 30, 2021 20,000.00
API Access

Immunic Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IMUX&period=max&api_key=YOUR_API_KEY